MoonLake Immunotherapeutics (MLTX)

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $1.20 billion. The enterprise value is $910.80 million.

Market Cap	1.20B
Enterprise Value	910.80M

Important Dates

The last earnings date was Wednesday, February 25, 2026, before market open.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

MLTX has 71.73 million shares outstanding. The number of shares has increased by 2.54% in one year.

Current Share Class	71.73M
Shares Outstanding	71.73M
Shares Change (YoY)	+2.54%
Shares Change (QoQ)	+7.26%
Owned by Insiders (%)	10.50%
Owned by Institutions (%)	41.56%
Float	35.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.92
P/TBV Ratio	4.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.27, with a Debt / Equity ratio of 0.25.

Current Ratio	9.27
Quick Ratio	8.77
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.78

Financial Efficiency

Return on equity (ROE) is -60.78% and return on invested capital (ROIC) is -36.59%.

Return on Equity (ROE)	-60.78%
Return on Assets (ROA)	-33.92%
Return on Invested Capital (ROIC)	-36.59%
Return on Capital Employed (ROCE)	-64.61%
Weighted Average Cost of Capital (WACC)	10.86%
Revenue Per Employee	n/a
Profits Per Employee	-$1.75M
Employee Count	130
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MLTX has paid $611,000 in taxes.

Income Tax	611,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.93% in the last 52 weeks. The beta is 1.24, so MLTX's price volatility has been higher than the market average.

Beta (5Y)	1.24
52-Week Price Change	-55.93%
50-Day Moving Average	16.55
200-Day Moving Average	29.42
Relative Strength Index (RSI)	47.30
Average Volume (20 Days)	1,165,178

Short Selling Information

The latest short interest is 7.04 million, so 9.81% of the outstanding shares have been sold short.

Short Interest	7.04M
Short Previous Month	7.27M
Short % of Shares Out	9.81%
Short % of Float	19.83%
Short Ratio (days to cover)	5.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-244.83M
Pretax Income	-229.71M
Net Income	-227.32M
EBITDA	-242.22M
EBIT	-244.83M
Earnings Per Share (EPS)	-$3.53

Balance Sheet

The company has $393.97 million in cash and $75.71 million in debt, with a net cash position of $318.26 million or $4.44 per share.

Cash & Cash Equivalents	393.97M
Total Debt	75.71M
Net Cash	318.26M
Net Cash Per Share	$4.44
Equity (Book Value)	304.48M
Book Value Per Share	4.27
Working Capital	376.22M

Cash Flow

In the last 12 months, operating cash flow was -$196.01 million and capital expenditures -$35,000, giving a free cash flow of -$196.04 million.

Operating Cash Flow	-196.01M
Capital Expenditures	-35,000
Free Cash Flow	-196.04M
FCF Per Share	-$2.73

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.54%
Shareholder Yield	-2.54%
Earnings Yield	-18.50%
FCF Yield	-15.95%

Analyst Forecast

The average price target for MLTX is $29.73, which is 77.18% higher than the current price. The consensus rating is "Buy".

Price Target	$29.73
Price Target Difference	77.18%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1